The Asia Pacific Single-use Assemblies Market would witness market growth of 23.9% CAGR during the forecast period (2022-2028).
The uniformity of design does not equate to the commoditization of single-use items, and there are several options to impart distinctiveness among single-use vendors while achieving economic and operational benefits. In recent years, practically every sterile business has shifted at least a portion, if not all, of the equipment used in their production process to a single-use substitute for standard stainless steel.
Single-use equipment eliminates cross-product/batch contamination hazards, boosts product integrity, decreases downtime, reduces cleaning costs, reduces facility setup costs, offers a smaller manufacturing footprint, and enhances facility flexibility and adaptability. In recent years, CMOs have included single-use assemblies into the majority or the entirety of their bioprocesses.
CMOs commonly employ single-use assemblies to expedite processing and process changes. Single-use assemblies' short turnaround time and adaptability between process cycles and diverse customer projects can increase the CMO's productivity, which in turn reduces overall costs. Moreover, an increasing percentage of CMO sites are effectively single-use.
The Indian pharmaceutical sector plays a significant part in the pharmaceuticals market throughout the world. According to the National Investment Promotion and Facilitation Agency, India is third globally in terms of production by volume as well as fourteenth by value. The nation is the largest producer of generic medications, accounting for 20% of supply by volume across the world, and the world's leading manufacturer of vaccines. India is home to more than 3,000 pharma businesses with a robust network of over 10,500 manufacturing sites and a highly qualified resource pool.
The China market dominated the Asia Pacific Single-use Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $646.3 million by 2028. The Japan market is estimated to grow a CAGR of 23.2% during (2022 - 2028). Additionally, The India market would experience a CAGR of 24.7% during (2022 - 2028).
Based on Solution, the market is segmented into Standard Solutions and Customized Solutions. Based on Product, the market is segmented into Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, and Others. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes. Based on Application, the market is segmented into Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Single-use Assemblies Market is Projected to reach USD 8.6 Billion by 2028, at a CAGR of 23.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech S.A. (Sartorius AG), Danaher Corporation, Merck Group, Avantor, Inc., Parker-Hannifin Corporation, Saint-Gobain Group (CertainTeed), Corning Incorporated, Repligen Corporation, and Entegris, Inc.
By Solution
By Product
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 